Cystic Fibrosis Transmembrane Conductance Regulator
"Cystic Fibrosis Transmembrane Conductance Regulator" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A chloride channel that regulates secretion in many exocrine tissues. Abnormalities in the CFTR gene have been shown to cause cystic fibrosis. (Hum Genet 1994;93(4):364-8)
| Descriptor ID |
D019005
|
| MeSH Number(s) |
D12.776.157.530.100.304.500 D12.776.157.530.400.175.125 D12.776.157.530.450.074.500.500.500.500 D12.776.543.550.450.175.125 D12.776.543.585.100.304.500 D12.776.543.585.400.175.125 D12.776.543.585.450.074.500.500.500.500
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Cystic Fibrosis Transmembrane Conductance Regulator".
Below are MeSH descriptors whose meaning is more specific than "Cystic Fibrosis Transmembrane Conductance Regulator".
This graph shows the total number of publications written about "Cystic Fibrosis Transmembrane Conductance Regulator" by people in this website by year, and whether "Cystic Fibrosis Transmembrane Conductance Regulator" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 1 | 0 | 1 |
| 2009 | 1 | 0 | 1 |
| 2012 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2016 | 2 | 1 | 3 |
| 2017 | 14 | 10 | 24 |
| 2018 | 18 | 5 | 23 |
| 2019 | 4 | 5 | 9 |
| 2021 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Cystic Fibrosis Transmembrane Conductance Regulator" by people in Profiles.
-
Reply to Eisenhut. Am J Physiol Lung Cell Mol Physiol. 2021 07 01; 321(1):L287-L289.
-
Potential value of circulating endothelial cells for the diagnosis and treatment of COVID-19. Int J Infect Dis. 2021 Jun; 107:232-233.
-
Dysfunctional Inflammation in Cystic Fibrosis Airways: From Mechanisms to Novel Therapeutic Approaches. Int J Mol Sci. 2021 Feb 16; 22(4).
-
A bird eye view on cystic fibrosis: An underestimated multifaceted chronic disorder. Life Sci. 2021 Mar 01; 268:118959.
-
Host genetic effects in pneumonia. Am J Hum Genet. 2021 01 07; 108(1):194-201.
-
Changing landscape: psychological care in the era of cystic fibrosis transmembrane conductance regulator modulators. Curr Opin Pulm Med. 2020 11; 26(6):696-701.
-
Are cystic fibrosis mutation carriers a potentially highly vulnerable group to COVID-19? J Cell Mol Med. 2020 11; 24(22):13542-13545.
-
Autophagy Augmentation to Alleviate Immune Response Dysfunction, and Resolve Respiratory and COVID-19 Exacerbations. Cells. 2020 08 24; 9(9).
-
COVID-19 meets Cystic Fibrosis: for better or worse? Genes Immun. 2020 08; 21(4):260-262.
-
Transcriptomic Responses to Ivacaftor and Prediction of Ivacaftor Clinical Responsiveness. Am J Respir Cell Mol Biol. 2019 11; 61(5):643-652.